Efficacy and Safety of Stannsoporfin in Neonates

Clinical trial NCT02685137 · COMPLETED

Trial details

NCT number: NCT02685137
Sponsor: InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Nutritional and Metabolic Diseases

Start date: 2002-05-01
Primary completion: 2003-03-16
Enrollment: 185

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.